Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avika Dixit

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
BMJ Global Health|March 28, 2024
Estimation of country-specific tuberculosis resistance antibiograms using pathogen genomics and machine learningAvika Dixit, Luca Freschi, Roger Vargas, et al.
Expert Review of Vaccines|September 5, 2024
A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and childrenFrances Priddy, Spyros Chalkias, Brandon Essink, et al.
The Journal of Infectious Diseases|May 31, 2024
Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western IndiaAvika Dixit, Yasha Ektefaie, Anju Kagal, et al.
Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
The Lancet. Infectious Diseases|March 22, 2024
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trialAvika Dixit, Richard Bennett, Kashif Ali, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2021
Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in IndiaSachin R Atre, Jayshri D Jagtap, Mujtaba I Faqih, et al.
Nature Communications|August 29, 2024
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phasesLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
BMJ Global Health|March 28, 2024
Estimation of country-specific tuberculosis resistance antibiograms using pathogen genomics and machine learningAvika Dixit, Luca Freschi, Roger Vargas, et al.
Expert Review of Vaccines|September 5, 2024
A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and childrenFrances Priddy, Spyros Chalkias, Brandon Essink, et al.
The Journal of Infectious Diseases|May 31, 2024
Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western IndiaAvika Dixit, Yasha Ektefaie, Anju Kagal, et al.
Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
The Lancet. Infectious Diseases|March 22, 2024
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trialAvika Dixit, Richard Bennett, Kashif Ali, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2021
Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in IndiaSachin R Atre, Jayshri D Jagtap, Mujtaba I Faqih, et al.
Nature Communications|August 29, 2024
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phasesLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Pageof 3